Signify Health announced the expansion of its in-home Diagnostic and Preventive Services offering for Medicare Advantage and Medicaid plan members. The offering supports the early detection, diagnosis, and management of some of the leading causes of morbidity and mortality among Medicare members, including chronic obstructive pulmonary disease (COPD), peripheral arterial disease, colorectal cancer, chronic kidney disease, diabetes, and low bone density. These diagnostic and preventive services are performed during the Signify Health In-Home Health Evaluation to deliver a comprehensive and convenient care experience to patients.

Signify Health's newest Diagnostic and Preventive Services offering is spirometry testing to detect COPD, which it began offering in select geographies in 2022. COPD is the fourth leading cause of death in the United States. Despite the high prevalence of COPD, the CDC estimates that just 50% of people living with the disease have been diagnosed.

There is no cure for COPD, but early diagnosis and treatment are critical to slow disease progression and reduce the risk of mortality.